ABSTRACT. SOX2, a universal marker of pluripotent stem cells, is a transcription factor that helps control embryonic development in vertebrates; its expression persists in neural stem/progenitor cells into adulthood. Considering the critical role of the SOX2 transcription factor in the regulation of genes required for self-renewal and pluripotency of stem cells, we developed and characterized SOX2-overexpressing NT2/D1 cell clones. Using Southern blot and semiquantitative RT-PCR, we confirmed integration and expression of exogenous SOX2 in three NT2/D1 cell clones. Overexpression of the SOX2 gene was detected in two of these clones. SOX2 overexpression in NT2/D1 cell clones resulted in altered expression of key pluripotency genes OCT4 and NANOG. Furthermore, SOX2-overexpressing NT2/D1 cell clones entered into retinoic acid-dependent neural differentiation, even when there was elevated SOX2 expression. After 21 days of induction by retinoic acid, expression of neural markers (neuroD1 and synaptophysin) was higher in induced cell clones than in induced parental cells. The cell clone with SOX2 overexpression had an approximately 1.3-fold higher growth rate compared to parental cells. SOX2 overexpression did not increase the population of cells undergoing apoptosis. Taken together, we developed two SOX2- overexpressing cell clones, with constitutive SOX2 expression after three weeks of retinoic acid treatment. SOX2 overexpression resulted in altered expression of pluripotency-related genes, increased proliferation, and altered expression of neural markers after three weeks of retinoic acid treatment.
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INTRODUCTION
To elucidate mechanisms underlying the control of pluripotency/self-renewal of stem cells, and subsequent cell differentiation, several studies have focused on studying the effects of modulation of Sox2 gene expression in embryonic stem (ES) and embryonal carcinoma (EC) cells (Mitsui et al., 2003; Zhao et al., 2004; Masui et al., 2007; Kopp et al., 2008; Adachi et al., 2010) . Sox2, a universal marker of pluripotent stem cells, is expressed in the neural tube from the earliest stages of development and is required to maintain neural progenitor cells in a naive state (Graham et al., 2003) . Additionally, Sox2 plays a role in later developmental stages, such as neural differentiation, proliferation and/or maintenance of neural stem cells (Episkopou, 2005) and its expression in the regions of adult neurogenesis is responsible for the maintenance and/or proliferation of adult neural stem cells (Ferri et al., 2004) . Studies based on manipulation of Sox2 gene expression have demonstrated that reduction of Sox2 in ES cells induces trophoectoderm and endoderm differentiation (Masui et al., 2007; Adachi et al., 2010) , while Sox2 overexpression promotes differentiation into neuroectoderm, mesoderm and trophoectoderm (Zhao et al., 2004; Kopp et al., 2008; Adachi et al., 2010) . Furthermore, it was demonstrated that a transient increase in the expression of Sox2 in murine F9 EC cells reduced the endogenous expression of Sox2, Nanog, , and Utf1 mRNA (Boer et al., 2007) .
NT2/D1 is a widely characterized pluripotent EC cell line that resembles early ES cells in morphology, antigen expression patterns, biochemistry, developmental potential, and gene regulation (Andrews, 1984) . In the presence of retinoic acid (RA), NT2/D1 cells differentiate along the neuronal lineage (Andrews, 1984) , providing an in vitro model system for studying cell differentiation. Moreover, after treatment with RA, NT2 cells have been used for transplantation cell therapy for brain injury, ischemia and neurodegenerative diseases in animal models, as well as in two clinical trials for human stroke patients (reviewed in Newman et al., 2005) . Furthermore, it was previously reported that SOX2 is expressed in NT2/D1 cells and that treatment of these cells with RA is accompanied by significant down-regulation of SOX2 during early phases of induction (Stevanovic, 2003) .
The aim of this study was to modulate SOX2 expression in order to elucidate the role of this transcription factor in EC NT2/D1 cell pluripotency, proliferation and differentiation. We have shown that increased SOX2 expression in NT2/D1 cell clones influences expression of key pluripotency genes and the ability of these cells to proliferate. Furthermore, these cell clones differentiate even in the presence of elevated SOX2 expression. At the same time, treatment with RA for 21 days results in up-regulation of neural markers in SOX2-overexpressing cell clones.
SOX2-overexpressing NT2/D1 cell clones

MATERIAL AND METHODS
Establishment of a stable SOX2-overexpressing NT2/D1 cell line
The pcDNA3.1/SOX2 construct was obtained by ligation of an EcoRI-XbaI fragment, containing full-length human SOX2 cDNA (Stevanovic et al., 1994) , into the EcoRI and NheI sites of expression vector pcDNA3.1. The resulting construct was transfected into NT2/D1 cells using the calcium phosphate precipitation method (Chen and Okayama, 1987) . The cells were maintained as previously described (Andrews, 1984) . Cells were subjected to drug selection 48 h after transfection by adding G418 (GibcoBRL) to the culture medium (400 μg/mL). G418-resistant, individual colonies were isolated after 3 weeks of culture, with change of the G418-containing medium every 3 days. To assess differentiation potential, NT2/D1 cells and SOX2-overexpressing cell clones were grown in media supplemented with 10 mM all-trans RA (Sigma) for a period of three weeks.
PCR detection of inserted DNA
In order to detect pcDNA3.1/SOX2 insertion into the genome, we performed PCR amplification with vector-specific T7 primer 5'-TAA TAC GAC TCA CTA TAG GG-3' (forward) and SOX2 gene-specific primer 5'-AGA TAC ATG CTG ATC ATG TCC-3' (reverse). Using this primer pair, only template originated from the pcDNA3.1/SOX2 construct could be amplified (product 860 bp in size).
Southern blot analysis
Integration of pcDNA3.1/SOX2 into the genome of NT2/D1 cells was verified by Southern blot. Briefly, 20 μg genomic DNA, digested with EcoRI restriction enzyme, was fixed on SensiBlot TM Plus Nylon Membrane (Fermentas); membranes were then fixed by UV cross-linking and hybridized with the SOX2-specific probe encompassing 3'-coding region.
Reverse transcriptase-PCR (RT-PCR) analysis
Total RNA from untreated or RA-treated NT2/D1 cells and SOX2-overexpressing cell clones was isolated using TRI-Reagent (Ambion) according to manufacturer instructions. RNA was treated using a DNA-Free TM kit (Ambion) and subjected to cDNA synthesis. Total RNA (1 μg) was reverse transcribed in the presence of 5 mM MgCl 2 (Fermentas), 1X Gold PCR Buffer (Applied Biosystems), 1 mM dNTPs (Pharmacia), 50 U MuLV Reverse Transcriptase (Applied Biosystems), 10 U RNase Inhibitor (Applied Biosystems), and 2.5 μM Random Hexamers (Applied Biosystems). Reactions were carried out at 23°C for 10 min, followed by 42°C for 15 min, denatured at 99°C for 5 min and then cooled to 4°C.
The synthesized cDNAs were amplified with primers specific for both endogenous and exogenous SOX2, exogenous SOX2 only, OCT4, NANOG, neuroD1, synaptophysin, and GAPDH (glyceraldehyde 3-phosphate dehydrogenase). Primer sequences for amplification of exogenous SOX2 were: 5'-ACC AGC TCG CAG ACC TAC AT-3' (forward) and 5'-TCC GCC TCA GAA GCC ATA GA-3' (reverse). Forward primer is from SOX2-coding sequence while reverse primer is from artificial 3'-UTR within the pcDNA3.1, thus enabling amplification of transcript solely originated from pcDNA3.1/SOX2 construct yielding a 757-bp product. Primer sequences for amplification of overall SOX2 were: 5'-CCC CTG GCA TGG CTC TTG GC-3' (forward) and 5'-TCG GCG CCG GGG AGA TAC AT-3' (reverse). This primer pair that originated from SOX2-coding sequence enables amplification of both exogenous and endogenous SOX2 yielding a 150-bp product. OCT4 was amplified with primers: 5'-GCT TTG AGG CTC TGC AGC TT-3' (forward) and 5'-TCT CCA GGT TGC CTC TCA CT-3' (reverse); NANOG with primers: 5'-GGT CCC GGT CAA GAA ACA GA-3' (forward) and 5'-TCT GGA ACC AGG TCT TCA CC-3' (reverse); neuroD1 with primers: 5'-CCA AAA AGA AGA AGA TGA CTA AGG-3' (forward) and 5'-AGC TGT CCA TGG TAC CGT AA-3' (reverse); synaptophysin with primers: 5'-CTT CCT GAA CCT GGT GCT CT-3' (forward) and 5'-TAG CCT TGC TGC CCA TAG TC-3' (reverse); GAPDH with: 5'-GCC TCA AGA TCA TCA GCA ATG C-3' (forward) and 5'-CCA CGA TAC CAA AGT TGT CAT GG-3' (reverse). Expression of GAPDH was used to normalize levels of the total RNA used in assays. PCRs were performed in 20-μL reactions using KAPA 2G Fast HotStart Ready Mix (Kapa Biosystems). All samples were denatured 2 min at 95°C and then cycled at 95°C for 15 s, 60°C for 15 s and 72°C for 15 s, for 35 cycles, with reaction aliquots taken at 25 and 30 cycles. Controls without reverse transcription and without template were included (data not shown).
Western blot analysis
Whole cell lysates were prepared from NT2/D1 and SOX2-overexpressing cell clones. Samples were separated by SDS-PAGE on 12% resolving gel and then electrotransferred to nitrocellulose membrane (GE Healthcare). After blocking with 10% nonfat milk at room temperature for 1 h, membranes were incubated overnight at +4°C with the following primary antibodies: rabbit polyclonal antibodies against SOX2 (Abcam, ab15830) and mouse monoclonal antibodies against α-tubulin (Calbiochem, CP06). Immunoreactive bands were detected using an ECL kit (GE Healthcare).
MTT assay
NT2/D1 and SOX2-overexpressing cell clones were seeded at a density of 5 x 10 4 cells/well on 96-well plates, and incubated in DMEM containing 10% FCS. At the end of a 24-h culture period, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution was added to cell cultures at a final concentration of 1 mg/mL and cells were incubated for an additional 2 h at 37°C. Subsequently, medium was removed and cells were lysed in DMSO. The conversion of MTT to formazan by metabolically viable cells was monitored by microplate reader at a wavelength of 620 nm. The experiment was done in triplicate and repeated in 12 independent experiments. Cell clones were tested at passages 11-20.
Cell cycle assay
NT2/D1 and SOX2-overexpressing cell clones were harvested with Trypsin, washed twice with PBS and fixed in 70% ethanol for 2 h at 4°C. Subsequently, cells were washed with PBS, incubated with RNase (50 μg/mL) 15 min at 37°C and then with 40 μg/mL propidium SOX2-overexpressing NT2/D1 cell clones iodide (PI) 30 min at 37°C in the dark. Red fluorescence was analyzed on a FACSCalibur flow cytometer (BD Biosciences). Cell distribution among cell cycle phases was determined using the CellQuest Pro software (BD Biosciences). The experiment was performed three times.
RESULTS
Generation and initial characterization of NT2/D1 cells that stably overexpress the SOX2 gene
In order to establish stable overexpression of the SOX2 gene in human teratocarcinoma cell line NT2/D1, we cloned full-length human SOX2 cDNA (Stevanovic et al., 1994) into a pcDNA3.1 vector. Upon transfection of NT2/D1 cell line with a pcDNA3.1/SOX2 construct and selection using G418, we obtained 54 resistant colonies. Thirty-eight colonies died during propagation and afterwards we established 16 stable cell clones, which were subjected to further analysis.
Using oligonucleotides specific exclusively for SOX2 originating from a pcDNA3.1/ SOX2 construct we detected the presence of corresponding PCR product of 860 bp in six established cell clones (here referred to as F2, F5, G3, H2, I3, and I4) and by this we have demonstrated that integration occurred in these cell clones ( Figure 1A ). A. PCR on genomic DNA was performed using primer pairs specific for SOX2 originating from the pcDNA3.1/SOX2 construct. A 860-bp product was obtained in cell clones F2, F5, G3, H2, I3, and I4. Control reaction performed on NT2/D1 genomic DNA is presented as NT2; no DNA = negative control. White vertical lines separate merged gel fields. B. Southern blot analysis using SOX2-specific probe. Integration of the SOX2 cDNA construct into the genome of F2, F5 and G3 cell clones was detected. Integration was not detected in cell clones H2, I3 and I4. White vertical lines separate merged membrane fields. NT2 = genomic DNA from NT2/D1 cells; Black arrow = endogenous SOX2; gray arrows = exogenous SOX2 size indicator; white arrowheads = exogenous SOX2; asterisk = SOX2 gene-related copy.
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To confirm integration of the SOX2 expression construct, Southern blot was carried out on six previously selected cell clones, as well as on the parental NT2/D1 cell line ( Figure  1B) . As a result of hybridization with an SOX2-specific probe we detected a 5-kb band in all cells analyzed, representing an endogenous SOX2 gene copy. Southern blot analysis confirmed the integration of the SOX2 cDNA construct into the genome of F2, F5 and G3 cell clones. We also detected the presence of an additional 2.5-kb band in the F5 cell clone, which is likely the result of integration of fragmented pcDNA3.1/SOX2 ( Figure 1B ). Since the integration was not confirmed by Southern blot analysis, cell clones H2, I3 and I4 were excluded from further analysis.
By semi-quantitative RT-PCR analysis, using forward primer specific for the SOX2-coding sequence and reverse primer originated from artificial 3'-UTR, we confirmed expression of exogenous SOX2 in cell clones F2, F5 and G3 ( Figure 2A ). Relative quantification of exogenous SOX2 expression did not reveal a statistically significant difference between cell clones F2 and F5, while cell clone G3 has almost three times the expression of exogenous SOX2, when compared to F2 (Figure 2A ). A. RT-PCR analysis of exogenous (ex.) SOX2 expression in F2, F5 and G3 cell clones. PCR product was not detected in parental NT2/D1 cells that served as control. B. RT-PCR analysis of overall SOX2 expression in F2, F5 and G3 cell clones. SOX2 expression is increased by approximately 1.7-and 3.1-fold in F5 and G3 cell clones, respectively, while approximately the same level of overall SOX2 expression is detected in F2 cell clone and NT2/D1 cells. Three independent experiments were performed and representative composite images are shown, with white vertical lines separating merged gel fields. Bands were digitalized, quantified with the ImageJ software and normalized for GAPDH values. The relative gene expression was calculated as a fold expression compared to F2 cell clone (A) or compared to parental NT2/D1 cells (B), which were set as 1. Data of three independent experiments are presented in a histogram as the means ± SD. NT2 = NT2/D1 cells; F2, F5, G3 = NT2/D1 cell clones. *P ≤ 0.001.
Furthermore, in order to determine overall SOX2 expression, semi-quantitative RT-PCR analysis was performed using primer pair specific for both endogenous and exogenous SOX2 ( Figure 2B ). The overall SOX2 expression in F5 and G3 cell clones was increased by approximately 1.7-and 3.1-fold, respectively, when compared to the parental NT2/D1 cells. At the same time approximately the same overall SOX2 expression was detected in the F2 cell clone and parental cells and accordingly the F2 cell clone was excluded from further analysis.
The overall expression of the SOX2 protein in F5 and G3 cell clones was determined by Western blot analysis (Figure 3) . Our results confirm the abundance of the SOX2 protein in NT2/D1 cells, as previously reported (Perrett et al., 2008) . Furthermore, our results demonstrate that overall SOX2 protein expression was higher in F5 and G3 cell clones, compared to parental cells.
Taken together, our results confirmed the generation of two SOX2-overexpressing cell clones that were subjected to further analyses.
Expression profile of pluripotency-specific genes OCT4 and NANOG
Recent studies have demonstrated that transient overexpression of Sox2 in EC cells results in reduced promoter activity of pluripotency-specific genes, including Oct4 and Nanog (Boer et al., 2007) . Furthermore, it has been shown that overexpression of SOX2 in human ES cells decreases the level of OCT4 and NANOG (Adachi et al., 2010) . Therefore, we examined whether SOX2 overexpression modulates the expression of OCT4 and NANOG in NT2/ D1 cells ( Figure 4A ). In F5 and G3 cell clones, the expression level of the OCT4 gene was decreased by approximately 2-fold when compared to the parental cell line ( Figure 4B ). However, NANOG expression was down-regulated by approximately one third in the F5 cell clone, while its expression was approximately 1.6-fold higher in the G3 cell clone, compared to the expression in NT2/D1 cells ( Figure 4C ). Obtained results imply that changes in overall SOX2 expression in F5 and G3 NT2/D1 cell clones (approximately 1.7 and 3.1 times higher) are able to alter the expression of key pluripotency genes OCT4 and NANOG. 
SOX2 overexpression and differentiation
In the presence of RA, NT2/D1 cells differentiate into various cell types, including terminally differentiated neurons and astrocytes (Andrews, 1984; Sandhu et al., 2002) . The ability of F5 and G3 cell clones to differentiate was followed by visual inspection during 21 days of culturing cells in media supplemented with RA ( Figure 5A ). Both cell clones and the parental cell line exerted the ability to grow in highly confluent foci (data not shown). However, a small fraction of the cells exhibited substantially altered morphology and developed cells resembling neurons ( Figure 5A ). Considering data that endogenous SOX2 expression is significantly down-regulated in NT2/D1 cells upon induction with RA (Stevanovic, 2003) , our next goal was to determine whether cell clones F5 and G3 retain SOX2 expression after 21 days of induction by RA. Relative quantification of overall SOX2 expression in NT2/D1 cells and F5 and G3 cell clones was assessed after three weeks of treatment with RA ( Figure 5B-D) . As expected, SOX2 expression in NT2/D1 cells was down-regulated by 2-fold when compared to their uninduced counterpart cells ( Figure 5D ). The analysis revealed that cell clones retained statistically significant SOX2 overexpression (approximately 1.4-and 2.3-fold increase RT-PCR analysis of OCT4 and NANOG in cell clones and parental NT2/D1 cells. OCT4 expression was decreased in F5 and G3 cell clones and NANOG expression was decreased in F5 and increased in G3 cell clones, compared with the NT2/D1 cells. Three independent experiments were performed and representative composite images are shown, with white vertical lines separating merged gel fields. Bands were digitalized, quantified with the ImageJ software and normalized for GAPDH values. The relative gene expression of OCT4 (B) and NANOG (C) were calculated as a fold expression of parental NT2/D1 cells, which were set as 1. Data of three independent experiments are presented in a histogram as the means ± SD. NT2 = NT2/D1 cells; F5, G3 = NT2/D1 cell clones. *P < 0.05. Genetics and Molecular Research 11 (2): 1385-1400 (2012) SOX2-overexpressing NT2/D1 cell clones in F5 and G3 cell clones, respectively) compared to NT2/D1 cells ( Figure 5C ). Interestingly, overall SOX2 expression in the G3 cell clone treated with RA for 21 days is approximately 1.3-fold higher when compared with uninduced parental NT2/D1 cells ( Figure 5D ). Expression of neural markers known to be involved in the formation of the vertebrate nervous system, such as neuroD1 and synaptophysin, was examined after 21 days of induction by RA (Figure 6 ). The expression of neuroD1 was not detected in uninduced cell clones and the parental cell line ( Figure 6A ). Relative quantification of neuroD1 expression revealed that expression of this neural marker in F5 and G3 cell clones treated with RA for 21 days is approximately 3.9-and 5.3-fold higher, respectively, when compared to induced NT2/D1 cells ( Figure 6B ). On the other hand, expression of synaptophysin was observed in uninduced cell clones and the parental cell line (Figure 6A,C) . After 21 days of induction with RA, synaptophysin expression was increased in all cells analyzed. In parental cell line expression this increase is approximately 3-fold, while in F5 and G3 cell clones expression this increase is approximately 6.3-and 10-fold, respectively, when compared to uninduced parental cells. Interestingly, expression of this marker in induced F5 and G3 cell clones is approximately 2-and 3.2-fold higher, respectively, when compared to induced parental cells. Taken together, up-regulation of neuroD1 and synaptophysin expression implies that SOX2-overexpressing cell clones are able to enter in RA-dependent pathway of neural differentiation, even in the presence of elevated SOX2 expression.
Proliferation rate of SOX2-overexpressing NT2/D1 cell clones
Previous studies demonstrated that SOX2 up-regulation could promote (Lang et al., 2011; Tompkins et al., 2011) or inhibit cell proliferation (Otsubo et al., 2008 ). Accordingly, we tested whether SOX2 overexpression has an influence on cell proliferation of NT2/D1 cells. By performing an MTT cell proliferation assay, we detected that the growth rate of the G3 cell clone is approximately 1.3-fold higher when compared to parental cells ( Figure 7A ). Since it was previously reported that the altered expression of SOX2 can influence cell cycle transition (Boyer et al., 2005; Chen et al., 2008; Otsubo et al., 2008) , we performed flow cytometry analysis by PI nuclei staining ( Figure 7B ). This analysis revealed that the relative distribution of cells in cell cycle phases was not altered in F5 and G3 cell clones when compared to parental NT2/D1 cells. Moreover, this analysis demonstrated that neither cell clone had an increased population of cells undergoing apoptosis (subG phase, Figure 7 ) as previously reported (Mitsui et al., 2003) . 
DISCUSSION
Sox2, a universal marker of pluripotent stem cells, is a transcription factor that plays a number of significant roles during embryonic development in vertebrates (Papanayotou et al., 2008) . This gene is expressed at high levels in neuroepithelial stem cells and its expression persists in neural stem/progenitor cells throughout adulthood (Miyagi et al., 2006) . Sox2 is highly expressed in ES and EC cells (Perrett et al., 2008; Schoenhals et al., 2009 ) and several studies have focused on modulating its expression in these cells in order to elucidate the role of this transcription factor in stem cell pluripotency and self-renewal (Zhao et al., 2004; Boer et al., 2007; Masui et al., 2007; Kopp et al., 2008; Adachi et al., 2010) .
Although the role of the Sox2 gene is extensively studied in ES cells, little is know about its function in the neural differentiation of EC cells. Accordingly, the aim of this study has been to generate SOX2-overexpressing NT2/D1 cell clones in order to elucidate the role of this transcription factor in NT2/D1 cell pluripotency, proliferation and differentiation. The study was initiated by engineering NT2/D1 cells overexpressing the human SOX2 gene. In order to avoid massive cell death, observed when Sox2 levels were elevated at least 4-fold above the endogenous level (Mitsui et al., 2003; Kopp et al., 2008; Tonge and Andrews, 2010) , we generated cell clones with SOX2 expression driven by cytomegalovirus immediate-early promoter (CMV-IE), which exhibited weak activity in ES and EC cells (Niwa et al., 1991; Liew et al., 2007) . The use of CMV-driven constitutive overexpression in NT2/D1 cells has been reported for several genes, such as pluripotency-related fibroblast growth factor-4 (FGF-4) and p27, as well as for FLJ11259/DRAM (Maerz et al., 1998; Baldassarre et al., 2000; Kerley-Hamilton et al., 2007) . Using this expression system we obtained 54 resistant colonies. However, although many colonies were produced, we established only 16 cell clones, presumably since SOX2 overexpression induced extensive cell death, as previously reported (Mitsui et al., 2003; Kopp et al., 2008; Tonge and Andrews, 2010) . Southern blot confirmed integration of the construct in three cell clones, while semi-quantitative RT-PCR revealed F5 and G3 cell clones with SOX2 expression 1.7-and 3.1-fold above the endogenous level, respectively. The increase in SOX2 expression obtained, although not very high, is in line with SOX2 overexpression achieved in previous studies showing that Sox2 expression of approximately 2-4-fold above the endogenous level affects expression of pluripotency-related genes and triggers differentiation (Kopp et al., 2008; Adachi et al., 2010) . Additionally, it has been reported that the CMV driven-expression system is active not only in undifferentiated ES cells, but also in their differentiated derivatives (Bagchi et al., 2006) . In line with these data, we have shown that SOX2 overexpression is active, not only in uninduced NT2/D1 cell clones, but also after treatment with RA for 21 days.
Both generated SOX2-overexpressing NT2/D1 cell clones exhibited morphology indistinguishable from that of parental NT2/D1 cells. Similarly, transient Sox2 overexpression of approximately 3-fold above endogenous level in F9 EC cells did not reveal any phenotypic effects (Boer et al., 2007) . Also, it has been shown that forced expression of Sox2 does not alter the undifferentiated, self-renewing phenotype of ES cells (Zhao et al., 2004) .
The transcription factors Sox2, Oct4 and Nanog are recognized as master regulators that orchestrate mammalian embryogenesis as well as the self-renewal and pluripotency of ES cells (Rizzino, 2008) . They play a key role in determining the fate of ES cells, regulating two distinct and opposing functions: self-renewal and differentiation (Rizzino, 2008) . Besides di-recting the expression of target genes, Sox2, Oct3/4 and Nanog regulate their own expression via positive-feedback loops (Boyer et al., 2005) . In both SOX2-overexpressing NT2/D1 cell clones analyzed in this study, OCT4 expression was down-regulated. Detected down-regulation is in concordance with results obtained in ES and EC cells overexpressing SOX2 (Boer et al., 2007; Adachi et al., 2010) . Interestingly, we have observed opposite effects of SOX2 overexpression on NANOG in two analyzed cell clones, with the up-regulation of NANOG in G3 and down-regulation in the F5 cell clone ( Figure 4C ). The role of Nanog in the interplay of key pluripotency factors is still poorly understood. Recent reports have postulated that maintenance of pluripotency does not require the constant presence of Nanog and that Nanog levels vary and reversibly change under appropriate self-renewal conditions (Chambers et al., 2007; Glauche et al., 2010) . Taken together, we might postulate that observed differences in NANOG expression in the NT2/D1 cell clones analyzed are not directly dependent on SOX2 levels. Alternatively, it is possible that SOX2 affects NANOG differently at different expression levels.
Previous studies demonstrated that up-regulation of Sox2 expression is associated with increased cell proliferation in the auditory nerve after injury (Lang et al., 2011) , as well as in respiratory epithelial cells (Tompkins et al., 2011) . On the other hand, SOX2 overexpression inhibited cell proliferation through cell-cycle (G1) arrest and apoptosis in gastric epithelial cell lines (Otsubo et al., 2008) . In this study, the G3 cell clone exhibits increased ability to proliferate. Although MTT assay revealed that the growth rate of the G3 cell clone was higher, the relative cell cycle distribution of these cells was not altered, when compared to NT2/D1 cells. We might postulate that mild overexpression of the SOX2 gene in the G3 cell clone may well correlate with shortening of all four cell cycle phases, with no change in the relative distribution of cells in G1, S, G2, and M phases, as previously described for Gfi-1 overexpressing Jurkat T-cells, which also have an increased proliferation rate (Karsunky et al., 2002) . Furthermore, sustained viability of the cell clones analyzed was demonstrated by flow cytometry, which did not reveal a notable population of apoptotic cells.
One of the most important features of NT2/D1 cells is the ability to differentiate towards ectodermal lineage upon RA induction (Andrews, 1984) . In response to RA, NT2 cells differentiate into neurons expressing transcription factors typically observed in the neurons found in dorsal and ventral forebrain, hindbrain and spinal cord (Coyle et al., 2011) . Importantly, post-mitotic NT2 neurons obtained by treatment with RA are able to generate action potentials and calcium spikes, express, release and respond to neurotransmitters (Houldsworth et al., 2001; Przyborski et al., 2000 Przyborski et al., , 2003 Coyle et al., 2011) .
Previously, it was reported that the RA-induced neuronal differentiation of NT2/D1 cells is accompanied by down-regulation of SOX2 (Stevanovic, 2003) . Additionally, it was demonstrated that constitutive expression of Sox2 in neural progenitors results in maintenance of proliferation and self-renewal, as well as in blocking of neuronal differentiation (Graham et al., 2003) . Furthermore, data obtained by Bylund et al. (2003) suggest that the generation of neurons from stem cells depends on the inhibition of Sox1-3 expression by proneural proteins. Accordingly, one of our goals was to analyze the effect of SOX2 overexpression on neural differentiation.
The three weeks of RA treatment of F5 and G3 cell clones resulted in a small population of cells morphologically resembling neurons, similar to the effect seen in parental NT2/ D1 cells ( Figure 5 ). Analysis of SOX2 expression after 21 days of RA treatment demonstrated that cell clones retained significant SOX2 overexpression, compared to treated parental cells.
Interestingly, overall SOX2 expression in the induced G3 cell clone is approximately 1.3-fold higher when compared to uninduced parental NT2/D1 cells ( Figure 5 ) and this cell clone still retains the ability to differentiate.
Differentiation of NT2/D1 cells into neurons could be divided into three sequential phases (Przyborski et al., 2000) . Phase 1 is characterized by the accumulation of nestin mRNA, while expression of neuroD1 and synaptophysin is up-regulated during phases 2 and 3, respectively (Przyborski et al., 2000) .
In order to analyze whether SOX2-overexpressing cell clones are able to enter into RA-dependent neural differentiation, we analyzed expression of neuroD1 and synaptophysin in cell clones and a parental cell line treated with RA for 21 days. In induced cell clones, as well as the induced parental line, we detected expression of neuroD1 and synaptophysin. Interestingly, expression of these two markers is higher in induced cell clones, compared to induced parental cells. Presently, we are not able to estimate whether the significant increase in neuroD1 and synaptophysin expression is the consequence of an increased number of cells expressing those markers. Alternatively, it is possible that SOX2 overexpression alters the expression of target genes, which in turn, by direct or indirect mechanisms, caused significant up-regulation of neuroD1 and synaptophysin. Additionally, we might postulate that SOX2 overexpression could lead to a delay in terminal neural differentiation, which enables intermediate cells to have more time to proliferate before terminally differentiating.
Taken together, we generated two SOX2-overexpressing NT2/D1 cell clones having constitutive SOX2 expression after three weeks of RA treatment. SOX2 overexpression resulted in altered expression of pluripotency-related genes, altered proliferation rates and altered expression of neural markers. Further study is needed to estimate whether intermediate neural cells demonstrating up-regulation of neuroD1 and synaptophysin have higher proliferative capacity and whether NT2/D1 cell clones, with constitutive SOX2 expression, have the ability to form neurosphere and to terminally differentiate.
